Introduction {#s001}
============

C[oronary artery disease]{.smallcaps} (CAD) and type 2 diabetes (T2D) are both chronic metabolic diseases triggered by several common factors and shared polygenic variants with high prevalence and morbidity (Alberti and Zimmet, [@B1]; King *et al.*, [@B11]). To our surprise, CAD is the leading cause of mortality and morbidity in patients with T2D and accounts for up to 80% of deaths in patients with this disorder (Doria, [@B5]). It has been hypothesized that T2D and CAD share a common genetic basis (Dong *et al.*, [@B4]), and the adiponectin signaling-related gene has been postulated to play critical roles in this scenario (Tao *et al.*, [@B19]).

Adiponectin is a functionally active adipokine that regulates glucose and lipid metabolism. The metabolic effects and biological function of adiponectin are mainly mediated by adiponectin receptor 1 (ADIPOR1) (Kadowaki and Yamauchi, [@B9]). So, ADIPOR1 plays an important role in indirectly regulating glucose and lipid metabolism in chronic metabolic diseases (Yamauchi *et al.*, [@B20]). The human *ADIPOR1* gene is located at chromosome 1p36.13-q41 and presents several polymorphisms (Yamauchi *et al.*, [@B20]). Some of these polymorphisms have been shown to be associated with an increased risk of developing several diseases, including obesity (Lacinov *et al.*, [@B12]), metabolic syndrome (Peters *et al.*, [@B15]), diabetes (Qi *et al.*, [@B16]), cardiovascular disease (Cox *et al.*, [@B2]), gastric cancer (Shin *et al.*, [@B18]), colorectal cancer (Liu *et al.*, [@B13]), and prostate cancer (Kaklamani *et al.*, [@B10]). However, to the best of our knowledge, there is only one report to date on the association of *ADIPOR1* variants with CAD, T2D, and T2D with CAD risk among the northern Han Chinese population (Jin *et al.*, [@B8]). Due to differences of genetic background, gene variation association studies may vary among populations in allele frequencies and linkage disequilibrium (LD) structures. It is important to examine multiple ethnic populations for the identification of ethnicity-specific loci as well as common susceptibility loci (Deschamps *et al.*, [@B3]).

Therefore, we conducted a study assessing the association of *ADIPOR1* variants with CAD, T2D, and T2D with CAD in a northeast Han Chinese population. The study may lay a theoretical foundation for the common soil hypothesis.

Materials and Methods {#s002}
=====================

Ethics statement {#s003}
----------------

All participants agreed to the protocol of this study and provided written informed consent. The study protocol was approved by the local research ethics committee.

Participants {#s004}
------------

The study population included patients who self-identified as having a Han ethnic origin and permanent residents of the Jiamusi Heilongjiang area in northeast China. We enrolled a total of 1181 subjects containing 316 CAD, 295 T2D, and 302 T2D with CAD patients, as well as 268 healthy controls between October 2014 and May 2015. T2D was diagnosed according to World Health Organization criteria (Alberti and Zimmet, [@B1]), while classification of CAD patients was based on previous studies (Qi *et al.*, [@B17]). The patients in the T2D with CAD group met both of the above inclusion criteria. The control group comprised healthy individuals who had no dyslipidemia and abnormal glucose tolerance, as well as family history of CAD or T2D in first-degree relatives. The exclusion criteria were the same as the criteria of the previous study (Jin *et al.*, [@B8]).

Genotyping {#s005}
----------

Six single-nucleotide polymorphisms (SNPs) (rs7539542, rs3737884, rs1342387, rs16850797, rs12045862, and rs7514221) on chromosome 1q32 were selected for genotyping in the present study. Genomic DNA was extracted from frozen EDTA whole peripheral blood using a salting-out procedure. The SNPs were genotyped using the polymerase chain reaction--restriction fragment length polymorphism method, with the exception of rs12045862, which was genotyped using high-resolution melting curves--unlabeled probe genotyping analysis. To ensure the quality of genotyping, we selected randomly three samples of each genotype to be directly sequenced. No discrepancies were observed.

Statistical analyses {#s006}
--------------------

The statistical analyses were performed using SPSS version 17.0 software. Continuous parameters were presented as mean ± standard deviation (SD) and were compared using one-way analysis of variance (ANOVA). The normality of distributions of the continuous variables was assessed with the Kolmogorov--Smirnov test. Categorical data were given as proportions of all the samples and were compared using the Pearson\'s chi-square (χ^2^) test. The odds ratios (ORs) and 95% confidence interval (CI) were calculated to evaluate the strength of association between variables. Hardy--Weinberg equilibrium (HWE) was verified using a chi-square goodness-fit test. Pairwise LD and haplotype analysis were confirmed using the open-source software, SHEsis. Bonferroni correction was conducted for multiple comparisons. A two-tailed value of *p* ≤ 0.05 was considered to be statistically significant.

Results {#s007}
=======

Clinical characteristics {#s008}
------------------------

The prevalence of known chronic metabolic risk factors, including SBP, DBP, FBG, TG, TC, and LDL-C, appeared to be higher in each subgroup (CAD group, T2D group, and T2D with CAD group), while HDL-C was lower compared with the normal control (*p* \> 0.05).

SNP association analysis {#s009}
------------------------

We analyzed all SNPs and found a week pairwise LD for those SNPs. The observed genotype frequencies of the six polymorphisms conformed to the HWE in the control (*p* \> 0.05). The allele and genotypic frequencies are shown in [Table 1](#T1){ref-type="table"}. The G allele frequency for rs3737884 of each case subgroup (CAD, T2D, and T2D with CAD patients) was higher \[*p* = 1.82E-5, OR = 1.770, 95% CI (1.362--2.301); *p* = 7.24E-6, OR = 1.844, 95% CI (1.409--2.413); *p* = 6.54E-6, OR = 1.842, 95% CI (1.410--2.406)\] compared with the control. However, the C allele for rs16850797 only conferred risk for the T2D and T2D with CAD groups \[*p* = 0.001, OR = 1.529, 95% CI (1.181--1.980); *p* = 0.001, OR = 1.571, 95% CI (1.217--2.028)\]. In addition, the allele C of rs7514221 was also positively associated with the three diseases \[*p* = 0.004, OR = 1.629, 95% CI (1.165--2.276); *p* = 0.002, OR = 1.674, 95% CI (1.194--2.347); *p* = 0.002, OR = 1.702, 95% CI (1.217--2.382)\].

###### 

[The Allele and Genotypic Frequencies of ADIPOR1 SNPs]{.smallcaps}

               *Control (*n* = 268)*   *CAD (*n* = 316)*                         *T2D (*n* = 295)*   *T2D with CAD (*n* = 302)*                                                                                    
  ------------ ----------------------- ----------------------------------------- ------------------- ----------------------------------------- ------------ ----------------------------------------- ------------ -----------------------------------------
  rs7539542                                                                                                                                                                                                        
   C           199 (37.1)              0.784                                     220 (34.8)          0.410                                     215 (36.4)   0.81                                      210 (34.8)   0.407
   G           337 (62.9)                                                        412 (65.2)          0.904                                     375 (63.6)   0.970                                     394 (65.2)   0.902
   CC          45 (16.8)               0.165                                     34 (10.8)           (0.711--1.149)                            36 (122)     (0.761--1.237)                            43 (14.2)    (0.708--1.150)
   CG          109 (40.7)                                                        152 (48.1)          0.056                                     143 (48.5)   0.115                                     124 (41.1)   0.684
   GG          114 (42.5)                                                        130 (41.1)                                                    116 (39.3)                                             135 (44.7)    
  rs3737884                                                                                                                                                                                                        
   G           362 (67.5)              9.47E-7^[a](#tf2){ref-type="table-fn"}^   497 (78.6)          1.82E-5^[b](#tf3){ref-type="table-fn"}^   468 (79.3)   7.24E-6^[c](#tf4){ref-type="table-fn"}^   479 (79.3)   6.54E-6^[d](#tf5){ref-type="table-fn"}^
   A           174 (32.5)                                                        135 (21.4)          1.770                                     122 (20.7)   1.844                                     125 (20.7)   1.842
   GG          127 (47.4)              3.67E-7^[a](#tf2){ref-type="table-fn"}^   198 (62.7)          (1.362--2.301)                            184 (62.4)   (1.409--2.413)                            192 (63.5)   (1.410--2.406)
   AG          108 (40.3)                                                        101 (32.0)          2.00E-4^[b](#tf3){ref-type="table-fn"}^   100 (33.9)   3.60E-5^[c](#tf4){ref-type="table-fn"}^   95 (31.5)    8.00E-5^[d](#tf5){ref-type="table-fn"}^
   AA          33 (12.3)                                                         17 (5.3)                                                      11 (62.4)                                              15 (5.0)      
  rs1342387                                                                                                                                                                                                        
   A           201 (37.5)              0.619                                     255 (40.6)          0.27                                      237 (40.2)   0.358                                     227 (38.0)   0.873
   G           335 (62.5)                                                        373 (59.4)          1.139                                     353 (59.8)   1.118                                     371 (62.0)   1.019
   AA          43 (16.1)               0.688                                     57 (18.2)           (0.899--1.44)                             51 (17.3)    (0.880--1.422)                            41 (13.7)    (0.802--1.297)
   AG          115 (42.9)                                                        141 (44.9)          0.057                                     135 (45.8)   0.608                                     145 (48.5)   0.394
   GG          110 (41.0)                                                        116 (36.9)                                                    109 (36.9)                                             113 (37.8)    
  rs16850797                                                                                                                                                                                                       
   C           138 (25.7)              0.002^[a](#tf2){ref-type="table-fn"}^     196 (31.0)          0.047                                     201 (34.7)   0.001^[c](#tf4){ref-type="table-fn"}^     213 (35.3)   0.001^[d](#tf5){ref-type="table-fn"}^
   G           398 (74.3)                                                        436 (69.0)          1.293                                     379 (65.3)   1.529                                     391 (64.7)   1.571
   CC          21 (7.8)                0.001^[a](#tf2){ref-type="table-fn"}^     47 (14.9)           (1.002--1.675)                            36 (12.4)    (1.181--1.980)                            54 (17.9)    (1.217--2.028)
   CG          96 (35.9)                                                         102 (32.3)          0.029                                     129 (44.5)   0.005^[c](#tf4){ref-type="table-fn"}^     105 (34.8)   0.001^[d](#tf5){ref-type="table-fn"}^
   GG          151 (56.3)                                                        167 (52.8)                                                    125 (43.1)                                             143 (47.4)    
  rs12045862                                                                                                                                                                                                       
   C           248 (46.3)              0.05                                      324 (51.9)          0.055                                     298 (54.6)   0.016                                     303 (50.7)   0.139
   T           288 (53.7)                                                        300 (48.1)          1.234                                     248 (45.4)   1.395                                     295 (49.3)   1.192
   CC          64 (23.9)               0.14                                      84 (26.9)           (0.995--1.580)                            87 (31.9)    (1.098--1.772)                            79 (25.4)    (0.944--1.506)
   CT          120 (44.8)                                                        156 (50.0)          0.082                                     124 (45.4)   0.032                                     145 (48.5)   0.252
   TT          84 (31.3)                                                         72 (23.1)                                                     62 (22.7)                                              75 (25.1)     
  rs7514221                                                                                                                                                                                                        
   C           62 (11.6)               0.013^[a](#tf2){ref-type="table-fn"}^     111 (17.6)          0.004^[b](#tf3){ref-type="table-fn"}^     106 (18.0)   0.002^[c](#tf4){ref-type="table-fn"}^     110 (16.6)   0.002^[d](#tf5){ref-type="table-fn"}^
   T           474 (88.4)                                                        521 (82.4)          1.629                                     484 (82.0)   1.674                                     494 (83.4)   1.702
   CC          5 (1.9)                 0.017^[a](#tf2){ref-type="table-fn"}^     9 (2.8)             (1.165--2.276)                            9 (3.1)      (1.194--2.347)                            13 (2.3)     (1.217--2.382)
   CT          52 (19.4)                                                         93 (29.7)           0.018                                     88 (29.8)    0.009^[c](#tf4){ref-type="table-fn"}^     84 (26.8)    0.010^[d](#tf5){ref-type="table-fn"}^
   TT          211 (78.7)                                                        214 (67.7)                                                    198 (67.1)                                             205 (70.9)    

*p* ≤ 0.05/3 = 0.017. *n* refers to number of individuals. Values are given as allele or genotype frequencies, proportions (%), and OR (95% CI); differences were compared using the Pearson\'s χ^2^method.

Significance indicates difference between case and control *p* ≤ 0.05.

Significance indicates CAD versus control.

Significance indicates T2D versus control.

Significance indicates T2D with CAD versus control.

CAD, coronary artery disease; CI, confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism; T2D, type 2 diabetes.

Through genetic model analysis, we found that rs3737884\*G, rs16850797\*C, and rs7514221\*C are risk variants for CAD, T2D, and T2D with CAD in at least one of the three genetic models ([Table 2](#T2){ref-type="table"}, *p* \< 0.017).

###### 

[Association Between Related ADIPOR1 SNPs and CAD, T2D, and T2D with CAD in Common Genetic Models]{.smallcaps}

                *CAD/control*   *T2D/control*   *CAD+T2D/control*                                                        
  ------------- --------------- --------------- ------------------- ---------- ------- -------------- ---------- ------- --------------
  rs3737884                                                                                                              
   Codominant                                                                                                            
    GG          3.39E-4         3.026           1.618--5.660        2.02E-5    4.346   2.118--8.919   1.64E-4    3.326   1.736--6.376
    GA          0.068           1.815           0.952--3.450        0.005      2.778   1.333--5.791   0.051      1.935   0.991--3.784
    AA          Rf              ---             ---                 Rf         ---     ---            Rf         ---     ---
   Dominant                                                                                                              
    GG+GA       0.003           2.470           1.343--4.544        1.51E-04   3.626   1.793--7.330   0.002      2.687   1.425--5.066
    AA                                                                                                                    
   Recessive                                                                                                             
    GG          2.14E-4         1.863           1.338--2.593        3.55E-04   1.84    1.315--2.576   1.02E-04   1.938   1.386--2.710
    GA+AA                                                                                                                 
  rs16850797                                                                                                             
   Codominant                                                                                                            
    CC          0.012           2.024           1.156--3.541        0.014      2.071   1.150--3.729   2.92E-4    2.715   1.561--4.723
    CG          0.025           0.961           0.674--1.370        0.007      1.623   1.138--2.315   0.432      1.155   0.807--1.654
    GG          Rf              ---             ---                 Rf         ---     ---            Rf         ---     ---
   Dominant                                                                                                              
    CC+CG       0.398           1.151           0.830--1.597        0.002      1.704   1.219--2.384   0.032      1.435   1.031--1.997
    GG                                                                                                                    
   Recessive                                                                                                             
    CC          0.008           2.055           1.194--3.536        0.014      1.667   1.124--2.936   3.98E-04   2.561   1.502--4.368
    CG+GG                                                                                                                 
  rs7514221                                                                                                              
   Codominant                                                                                                            
    CC          0.305           1.775           0.585--5.383        0.243      1.918   0.632--5.822   0.057      2.676   0.937--7.641
    CT          0.004           1.763           1.195--2.602        0.003      1.803   1.216--2.674   0.011      1.663   1.119--2.470
    TT          Rf              ---             ---                 Rf         ---     ---            Rf         ---     ---
   Dominant                                                                                                              
    CC+CT       0.003           1.764           1.212--2.569        0.002      1.813   1.240--2.653   0.004      1.752   1.199--2.560
    TT                                                                                                                    
   Recessive                                                                                                             
    CC          0.439           1.542           0.510--4.658        0.367      1.655   0.548--5.002   0.097      2.366   0.832--6.727
    CT+TT                                                                                                                 

Values are given as OR and 95% CI. Differences were compared by Pearson\'s χ^2^ test. *p* ≤ 0.017 was considered to be statistically significant.

Haplotype GCT, which contains 3737884\*G, rs16850797\*C, and rs7514221\*T, was the most prevalent risk haplotype for patients with CAD, T2D, and T2D with CAD ([Table 3](#T3){ref-type="table"}, *p* \< 0.017).

###### 

[Haplotype Analysis for ADIPOR1 SNPs and CAD, T2D, and T2D with CAD]{.smallcaps}

  *Haplotype*                   *Case freq*      *Control freq*   *χ^2^*   p         *OR*    *95% CI*
  ----------------------------- ---------------- ---------------- -------- --------- ------- --------------
  CAD versus control                                                                          
   A C T                        15.21 (0.024)    24.56 (0.148)    4.046    0.044     0.518   0.271--0.994
   A G T                        114.23 (0.181)   147.70 (0.003)   14.404   1.49E-4   0.585   0.443--0.773
   G C T                        163.56 (0.259)   101.55 (0.189)   8.535    0.003     1.518   1.146--2.011
   G G C                        90.74 (0.144)    49.96 (0.093)    7.300    0.007     1.652   1.145--2.385
   C G T                        228.00 (0.361)   200.19 (0.106)   0.106    0.745     0.961   0.755--1.222
  T2D versus control                                                                         
   A C T                        20.54 (0.035)    24.56 (0.046)    0.745    0.387     0.769   0.423--1.399
   A G T                        100.36 (0.173)   147.70 (0.276)   16.652   4.54E-5   0.552   0.414--0.736
   G C T                        164.34 (0.018)   101.55 (0.068)   14.026   1.82E-4   1.711   1.290--2.270
   G G C                        88.84 (0.153)    49.96 (0.093)    9.440    0.002     1.774   1.227--2.567
   C G T                        189.76 (0.327)   200.19 (0.373)   2.448    0.117     0.820   0.640--1.051
  T2D with CAD versus control                                                                
   A C T                        25.26 (0.042)    24.56 (0.046)    0.095    0.758     0.915   0.518--1.614
   A G T                        94.28 (0.156)    147.70 (0.276)   23.773   1.10E-6   0.489   0.366--0.654
   G C T                        164.02 (0.272)   101.55 (0.189)   11.088   8.74E-4   1.608   1.214--2.130
   G G C                        68.10 (0.113)    49.96 (0.093)    1.242    0.265     1.245   0.847--1.830
   G G T                        225.43 (0.373)   200.19 (0.373)   0.004    0.947     1.008   0.792--1.283

All those with frequency \<0.03 in both the case and control were excluded from the analysis. Pearson\'s χ^2^ analysis was performed; a significance level was set at *p* ≤ 0.05.

Discussion {#s010}
==========

*ADIPOR1* variant, rs3737884\*G, was associated with the susceptibility of CAD, T2D, and T2D with CAD, but rs16850797\*C was associated with T2D and T2D with CAD, which has only been reported in a northern Han Chinese population (Jin *et al.*, [@B8]). There are different effects of genetics backgrounds on the disease in different ethnic groups, so an estimate of genetic effect size from one genetic background is frequently biased and more precise estimates can be obtained in independent replication study. Therefore, we conducted a replication study to assess the association of *ADIPOR1* variants with T2D, CAD, and T2D with CAD in a northeast Han Chinese population.

Consistent with the above findings, we also identified a novel shared variant rs7514221\*C in *ADIPOR1* that is associated with CAD, T2D, and T2D with CAD susceptibility in our study. Our finding confirms that *ADPOR1* variant, rs3737884\*G, is a strong shared candidate for the three diseases in a Chinese Han population. SNP rs7514221\*C seems to be also a shared genetic variant of CAD, T2D, and T2D with CAD in our study population. Considering that this is the first study on the shared variant rs7514221, it should be verified in other populations.

Although rs16850797\*C was just associated with T2D and T2D with CAD, our haplotype analysis showed that GCT containing two risk variants (rs3737884\*G and rs16850797\*C) was the most prevalent at-risk haplotype for the three diseases. It seems to suggest that we should pay attention to the integrity of the gene when we try to identify the genetic variation associated with diseases (Hannou *et al.*, [@B7]).

The mechanisms through which variations in the *ADIPOR1* could influence CAD and T2D are only hypothetical at the moment. We suppose the two polymorphisms (rs3737884 and rs7514221) located inside intron of the *ADIPOR1* locus could influence adiponectin receptor expression levels and further physiologically modulate adiponectin metabolic activities in distal metabolically active tissues (Luo *et al.*, [@B14]).

However, we focused only on SNPs; numerous factors act individually and together to influence risk of the three diseases. So, we should involve more factors in our future work. Besides, further physiological and functional studies are also needed to reveal the molecular mechanisms and pathways underlying the associations with the three diseases (Ghanbari *et al.*, [@B6]).

Conclusion {#s011}
==========

Taken together, our study not only confirmed that *ADPOR1* variant, rs3737884\*G, was a strong shared risk variant for CAD, T2D, and T2D with CAD but also identified a novel risk factor, rs7514221\*C, shared with the three diseases in a population of northeast China.
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